Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,728.50
Bid: 1,727.00
Ask: 1,728.00
Change: 23.50 (1.38%)
Spread: 1.00 (0.058%)
Open: 1,705.00
High: 1,729.50
Low: 1,695.50
Prev. Close: 1,705.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UPDATE 1-Kenya becomes third African nation to introduce malaria vaccine

Fri, 13th Sep 2019 13:56

(Adds details of vaccine, statement from WHO Africa director)

NAIROBI, Sept 13 (Reuters) - Kenya on Friday began adding a
malaria vaccine to its routine immunization schedule for babies
and toddlers, becoming the third African country to roll out the
vaccine for a disease that threatens children across the
continent.

Malaria, which kills one child globally every two minutes,
is the top killer of children under five in the east African
country. The vaccine - the world's first against malaria - will
be administered to children under two and could be crucial to
efforts to combat the disease, health officials said.

Other measures, such as nets to protect people from the
mosquitoes that carry the malaria parasite, have not proven
adequate to halt transmission, the director general of Kenya's
health ministry, Wekesa Masasabi, told Reuters.

"We still have an incidence of 27% (malaria infection) for
children under five," Masasabi said before Friday's launch of
the vaccine in the western county of Homa Bay.

The Homa Bay programme is the government's first step toward
creating awareness of the new vaccine, he said.

The injectable vaccine, called RTS,S or Mosquirix, was
developed by British drugmaker GlaxoSmithKline to
protect children from the most deadly form of malaria in Africa.

In clinical trials it proved only partially effective and it
needs to be given in a four-dose schedule, but it is the first
regulator-approved vaccine against the disease.

It has already been deployed in pilot programmes in Ghana
and Malawi.

Malaria infected about 219 million people in 2017 and killed
around 435,000. The vast majority of malaria deaths are among
babies and children in the poorest parts of Africa. Due to
ongoing transmission, half the world's population is still at
risk of contracting the disease.

The World Health Organization's regional director for
Africa, Matshidiso Moeti, said the Kenyan, Ghanaian and Malawian
pilots would provide key information and data for a future WHO
policy on broader use of the vaccine in sub-Saharan Africa.

A recent surge in malaria cases and deaths in the region is
threatening gains in the fight against the disease, she said,
adding that the vaccine "has the potential to save tens of
thousands of lives."

Kenya plans to roll out RTS,S to eight of its 47 counties
over the next two years, Masasabi said.

In a major report published last weekend, global health
experts said malaria could be eradicated within a generation
with the right tools, funding and political will.

Commissioned by The Lancet medical journal, the report
contradicted the conclusions last month of a malaria review by
the WHO. The experts urged the U.N. agency not to shy away from
this "goal of epic proportions".
(Reporting by Maggie Fick in Niarobi and Kate Kelland in London
Editing by Tom Hogue and Frances Kerry)

More News
2 May 2024 19:57

GSK knew about Zantac cancer risk, attorneys tell jury in first trial

May 2 (Reuters) - U.S. attorneys for a woman who claims her colon cancer was caused by the now discontinued heartburn drug Zantac on Thursday told a jury in Chicago that pharmaceutical companies GSK and Boehringer Ingelheim knew the product could cause cancer if it was not handled properly but failed to warn the public.

Read more
2 May 2024 09:48

LONDON BROKER RATINGS: Deutsche Bank likes TP ICAP but says sell CMC

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and Wednesday:

Read more
1 May 2024 19:39

Bird flu testing shows more dairy products are safe, US FDA says

CHICAGO, May 1 (Reuters) - Preliminary results of tests on additional dairy products show that pasteurization inactivates the bird flu virus, the U.S. Food and Drug Administration said on Wednesday.

Read more
1 May 2024 17:31

UK's FTSE 100 slips ahead of Fed outcome, energy stocks weigh

FTSE 100 down 0.3%, FTSE 250 off 0.2%

*

Read more
1 May 2024 16:56

LONDON MARKET CLOSE: FTSE 100 down ahead of US interest rate decision

(Alliance News) - Stock prices in London closed mostly in the red on Wednesday, as investors eye the latest interest rate decision from the US Federal Reserve this evening.

Read more
1 May 2024 16:42

London close: Stocks fall ahead of US Fed decision

(Sharecast News) - London markets closed lower on Wednesday, as investors digested the latest UK manufacturing data and anticipated an impending policy announcement from the US Federal Reserve.

Read more
1 May 2024 11:55

LONDON MARKET MIDDAY: FTSE 100 treads water as Fed takes centre-stage

(Alliance News) - London's FTSE 100 traded off session highs heading into Wednesday afternoon, as some pre-Federal Reserve decision nerves kicked in.

Read more
1 May 2024 10:54

GSK raises profit outlook on strong vaccine, HIV drug sales

FY profit forecast raised to 8-10%

*

Read more
1 May 2024 08:57

LONDON MARKET OPEN: FTSE 100 shakes off New York slump before Fed

(Alliance News) - Stock prices in London opened mixed on Wednesday, with the FTSE 100 brushing off some pre-Federal Reserve decision trepidation to record an early rise, while the dollar climbed on the expectation that Jerome Powell will sound hawkish in his press conference later.

Read more
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.